Med. praxi. 2019;16(2):122-124

Hemoroidální onemocnění a možnosti jeho léčby

MUDr. Pavel Rutar
Interní oddělení Nemocnice Na Homolce, Praha

Na VI. kongrese praktických lékařů, konaném 15.–16. února 2019 v Ostravě, zazněla přednáška doc. MUDr. Petera Ihnáta, PhD., MBA,
z Fakultní nemocnice Ostrava na téma Hemoroidální onemocnění a možnosti jeho léčby.

Received: March 13, 2019; Accepted: March 13, 2019; Prepublished online: March 13, 2019; Published: April 15, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rutar P. Hemoroidální onemocnění a možnosti jeho léčby. Med. praxi. 2019;16(2):122-124.
Download citation

References

  1. Paysant J, Sansilvestri-Morel P, Bouskela E, Verbeuren TJ. Different flavonoids present in the micronized purified flavonoid fraction (Daflon 500 mg) contribute to its anti-hyperpermeability effect in the hamster cheek pouch microcirculation. Int Angiol. 2008; 27(1): 81-85. Go to PubMed...
  2. Garner RC, Garner JV, Gregory S, Whattam M, Calam A, Leong D. Comparison of the absorption of micronized (Daflon 500 mg) and nonmicronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting. J Pharm Sci. 2002; 91(1): 32-40. Go to original source... Go to PubMed...
  3. Cospite M. Double-blind, placebo-controlled evaluation of clinical activity and safety of Daflon 500 mg in the treatment of acute hemorrhoids. Angiology. 1994; 45: 566-573. Go to original source... Go to PubMed...
  4. Godeberge P. Daflon 500 mg is significantly more effective than placebo in the treatment of hemorrhoids. Phlebology. 1992; 7(Suppl. 2): 61-63.
  5. La Torre F, Nicolai AP. Clinical use of a micronized purified flavonoid fraction for treatment of symptoms after hemorrhoidectomy: results of a randomized, controlled clinical trial. Dis Colon Rectum. 2004; 47: 704-710. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.